Medical Advocates
HIV Infection/Disease
  Nervous System Disorders
New and Noteworthy      
General Reports 
 Treatment
Diagnosis/Diagnostics
 Central Nervous System Disorders
Peripheral Nervous System Disorders




 





 
HIV Systemic Disease Main New/Newsworthy  Home Page

Last Update: December 04, 2011
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
November 2011
 
General Reports
       

           Journal Papers, Abstracts, and Commentaries

 
John Cunningham Virus Antibody and Viremia as Predictors of Progressive Multifocal
Leukoencephalopathy in HIV-1-Infected Individuals.
Viscidi RP, Khanna N, Tan CS,  et al 
Clin Infect Dis. 2011 Aug 18
 Abstract

Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/
HIV-Associated Dementia.
Purohit V, Rapaka R, Shurtleff D.
 Mol Neurobiol. 2011 Jul 1.
Abstract

Treatment of neuro-AIDS on a neurological intensive care unit : Epidemiology and
predictors of outcome
Braicks O, Anneken K, Reichelt D, et al
 Nervenarzt. 2011 May 14.
Abstract

 Neurological complications of HIV infection in critically ill patients: clinical features and
outcomes.
Sonneville R, Ferrand H, Tubach F,  et al
J Infect. 2011 Feb 14..
 Abstract

HIV-associated dementia in the era of highly active antiretroviral therapy (HAART).
 Xia C, Luo D, Yu X, Jiang S, Liu S.
 Microbes Infect. 2011 Jan 21.
 Abstract

FULL-TEXT PDF ARTICLE
Severe course of Lyme neuroborreliosis in an HIV-1 positive patient;
case report and review of the literature.
van Burgel ND, Oosterloo M, Kroon FP, van Dam AP.
BMC Neurol. 2010 Nov 30;10(1):11
 Paper

Neurologic disease burden in treated HIV/AIDS predicts survival. A population-based study.
Vivithanaporn P, Heo G, Gamble J,  et al
Neurology. 2010 Aug 25.
 Abstract

Translational Research in NeuroAIDS: A Neuroimmune Pharmacology-Related
Course.
Brown A, Shiramizu B, Nath A, Wojna V.
J Neuroimmune Pharmacol. 2010 May 25
 Abstract

HIV-related opsoclonus-myoclonus-ataxia syndrome: Report on two cases.
Kanjanasut N, Phanthumchinda K, Bhidayasiri R.
Clin Neurol Neurosurg. 2010 Apr 26.
Abstract

Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.
Pendyala G, Fox HS.  
 Genome Med. 2010 Mar 30;2(3):22
 Abstract

Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral
Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics.
Nowacek AS, McMillan J, Miller R, et al 
J Neuroimmune Pharmacol. 2010 Mar 17
 Abstract

NeuroAIDS
Nakagawa M, Kondo M.
 Nippon Rinsho. 2010 Mar;68(3):502-7.
 Abstract

Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
Ettenhofer ML, Foley J, Castellon SA, Hinkin CH.
Neurology. 2010 Mar 10.
 Abstract

Pearls: Neurologic Complications of HIV/AIDS.
Berger JR.
|Semin Neurol. 2010 Feb;30(1):66-70.
 Abstract

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with
Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy.
Canestri A, Lescure FX, Jaureguiberry S, et al
Clin Infect Dis. 2010 Jan 25.
 Abstract

Neurologic Presentations of AIDS.
Singer EJ, Valdes-Sueiras M, Commins D, Levine A. 
Neurol Clin. 2010 Feb;28(1):253-275.
 Abstract

Functional Consequences of HIV-Associated Neuropsychological Impairment.
Gorman AA, Foley JM, Ettenhofer ML, et al
Neuropsychol Rev. 2009 May 27
 Abstract

Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008.
Joseph J, Clifford D, Douglas SD,  et al
 J Neuroimmune Pharmacol. 2009 May 20.
 Abstract
 
Neuropsychological Assessment of HIV-Infected Populations in International Settings.
Robertson K, Liner J, Heaton R. 
Neuropsychol Rev. 2009 May 20.
Abstract

FULL-TEXT PDF ARTICLE
Neurologic Complications of HIV Disease and Their Treatment.
Letendre SL, Ellis RJ, Everall I, et al
Top HIV Med. 2009 Apr-May;17(2):46-56.
 Paper

Acquired immunodeficiency syndrome and the blood-brain barrier.
Ivey NS, Maclean AG, Lackner AA.
J Neurovirol. 2009 Mar 22:1-12
 Abstract
 
Neurodegeneration and Ageing in the HAART Era.
Brew BJ, Crowe SM, Landay A, et al
J Neuroimmune Pharmacol. 2008 Dec 6.
 Abstract
 
NeuroAIDS in the Asia Pacific Region.
 Wright EJ, Nunn M, Joseph J, et al
J Neurovirol. 2008 Nov 22:1-9.
 Abstract
 
Neurological complications of HIV infection.
Arendt G, Nolting T.
Nervenarzt. 2008 Nov 22.
Abstract
 
Emerging issues in the neuropsychology of HIV infection.
Foley J, Ettenhofer M, Wright M, Hinkin CH
Curr HIV/AIDS Rep. 2008 Nov;5(4):204-11
 Abstract
 
FULL TEXT PDF ARTICLE
Neurologic Complications of HIV Disease and Their Treatment.
Letendre S, McCutchan JA, Ellis RJ.
Top HIV Med. 2008 Mar-Apr;16(1):15-22.
 Paper
 
HIV Preclinical-Clinical Therapeutics Research: central nervous system approaches.
Kopnisky KL, Bao J.   
J Neuroimmune Pharmacol. 2007 Mar;2(1):1-4.
 Abstract
 
Meeting Practical Challenges of a Trial Involving a Multitude of Treatment Regimens:
An Example of a Multi-Center Randomized Controlled Clinical Trial in NeuroAIDS.
May S, Letendre S, Haubrich R, et al
J Neuroimmune Pharmacol. 2007 Mar;2(1):97-104.
Abstract

Assessment of NeuroAIDS in the International Setting.
 Robertson KR, Hall CD.
J Neuroimmune Pharmacol. 2007 Mar;2(1):105-11.
 Abstract

Neurobiology of HIV, psychiatric and substance abuse comorbidity research:
Workshop report.
 Kopnisky KL, Bao J, Lin YW.   
 Brain Behav Immun. 2007 Mar 6;
 Abstract
 
Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection.
Valcour VG, Sithinamsuwan P, Nidhinandana S, et al
Neurology. 2007 Feb 13;68(7):525-7.
 Abstract
 
NeuroAIDS, drug abuse, and inflammation: building collaborative research activities.
Berman JW, Carson MJ, Chang L, et al
J Neuroimmune Pharmacol. 2006 Dec;1(4):351-99.
 Abstract
 
FULL-TEXT PDF ARTICLE
Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment:
a Brazilian experience.
Oliveira JF, Greco DB, Oliveira GC
Rev Soc Bras Med Trop. 2006 Mar-Apr;39(2):146-51
 PDF Paper
 
Neuroimmunity, drugs of abuse, and neuroAIDS.
Burdo TH, Katner SN 
J Neuroimmune Pharmacol. 2006 Mar;1(1):41-
 Abstract
 
The nervous system in early HIV infection: a prospective study through 7 years.
Samuelsson K, Pirskanen-Matell R, et al 
Eur J Neurol. 2006 Mar;13(3):283-91.
 Abstract
 
Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and
viral entry into the nervous system with a focus on neuroAIDS.
Buckner CM, Luers AJ, Calderon TM, et al
J Neuroimmune Pharmacol. 2006 Jun;1(2):160-81.
Abstract
 
Neurological Manifestations of HIV-Infection in the Era of Highly Active Antiretroviral
Therapy (HAART).
Arendt G.
 Fortschr Neurol Psychiatr. 2005 Oct;73(10):577-86
 Abstract
 
Recommendations for the Classification of HIV Associated Neuromanifestations in the
German DRG System.
Evers S, Fiori W, Brockmeyer N, Arendt G, et al  
Eur J Med Res. 2005 Sep 12;10(9):378-80.
Abstract
 
Neurocognitive Impairment and Survival in a Cohort of HIV-Infected Patients Treated with HAART.
Tozzi V, Balestra P, Serraino D
AIDS Res Hum Retroviruses. 2005 Aug;21(8):706-13.
Abstract
 
Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions
in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated
cryptococcosis.
Lortholary O, Sitbon K, Dromer F , et al   
Clin Microbiol Infect. 2005 Apr;11(4):296-30
 Abstract

Unusual form of neurocysticercosis associated with HIV infection.
Delobel P, Signate A, El Guedj M, et al.
Eur J Neurol. 2004 Jan;11(1):55-58
 Abstract

The changing pattern of HIV neuropathology in the HAART era.
Gray F, Chretien F, Vallat-Decouvelaere AV, et al 
J Neuropathol Exp Neurol 2003 May;62(5):429-40
 Abstract
 
Neurologic Complications of Human Immunodeficiency Virus-type 1 Infection.
Kim HJ, Kim SY, Lee KB, Lee KW, et al.
J Korean Med Sci 2003 Apr;18(2):149-57
 Abstract
 
    Conference Reports, Abstracts, and Posters
 
 
Neurologic Disease Burden in Treated HIV/AIDS Predicts Survival
P Vivithanaporn, G Heo(
(17th CROI)
Abstracts

POWERPOINT PRESENTATION
 Neurological Complications in the HAART Era 
S Letendre
 4th IAS Conference
 Presentation
Treatment
       
General Reports

       Journal Papers, Abstracts, and Commentaries  
 
 
Role of psychiatric medications as adjunct therapy in the treatment of HIV associated
neurocognitive disorders.
Ances BM, Letendre SL, Alexander T, Ellis RJ.
Int Rev Psychiatry. 2008 Feb;20(1):89-93
Abstract
 
Translational research models and novel adjunctive therapies for neuroAIDS.
Zink MC.
J Neuroimmune Pharmacol. 2007 Mar;2(1):14-9.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT PDF ARTICLE
Neurologic Complications of HIV Disease and Their Treatment.
 Letendre S, Ances B, Gibson S, Ellis RJ.
Top HIV Med. 2007 Apr-May;15(2):32-9.
 Paper

HIV Neurotoxicity: Potential Therapeutic Interventions.
 Wallace DR.
 J Biomed Biotechnol. 2006;2006(3):65741.
 Abstract

ARV/HAART

      Journal Papers, Abstracts, and Commentaries  

 
Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review.
Cysique LA, Brew BJ.
Neuropsychol Rev. 2009 May 9.
Abstract

Highly active antiretroviral therapy of neuro-AIDS : Side effects on the nervous system and interactions.
Husstedt IW, Reichelt D, Neuen-Jakob E, et al
Nervenarzt. 2009 Mar 27
 Abstract
 
Antiviral and Immunomodulatory Treatment for AIDS-Related Primary Central Nervous System
Lymphoma: AIDS Malignancies Consortium Pilot Study 019.
Aboulafia DM, Ratner L, Miles SA, Harrington WJ Jr.
Clin Lymphoma Myeloma. 2006 Mar;6(5):399-402.
 Abstract
 
ASPD Blunts the Effects of HIV and Antiretroviral Treatment on Event-Related Brain Potentials.
Bauer LO, Shanley JD.
Neuropsychobiology. 2005 Nov 24;53(1):17-25
Abstract

Sensorimotor Dysfunction in HIV/AIDS: Effects of Antiretroviral Treatment and Comorbid
Psychiatric Disorders.
Bauer LO, Ceballos NA, Shanley JD, Wolfson LI.
 AIDS. 2005 Mar 25;19(5):495-502.
 Abstract

    Conference Reports, Abstracts, and Posters

 
POSTER
Intermediate (12 Months) and Long-term (6 Years) Cognitive Response to HAART
in 2 Thai Cohorts
V Valcour P Sithinamsuwan, W Pumpradit, et al
(15 CROI)
 PDF Poster     Abstract
 
POSTER
Predictors of Clinical Outcome and Viro-immunological Response to cART in an Italian Cohort
of HIV-infected Naive Patients Affected by Neurological Disorders
M Giancola, P Lorenzini, A Cingolani, et al
(15 CROI)
PDF Poster    Abstract
 
POSTER
Central Nervous System Immune Activation Is Still Present after More than 4 Years of Effective
HAART
A Edén, R Price, S Spudich, et al
(13 CROI)
PDF Poster     Abstract
 
POSTER
 HIV-1 Tropism for the Central Nervous System: Brain-derived Envelope Glycoproteins with Lower
CD4 Dependence and Reduced Sensitivity to a Fusion Inhibitor
J Martin-Garcia,  F Gonzalez-Scarano
(13 CROI)
PDF Poster     Abstract
 
Better Antiretroviral Penetration into the Central Nervous System Is Associated with Lower CSF
Viral Load
S Letendre, E Capparelli, B Best, et al
(13 CROI)
 Abstract

Neurological Functioning and CNS Penetrating Antiretroviral Regimens
K Robertson, W Robertson, S Ford, et al
 (11 CROI)
 Abstract
   
  Presence of Nucleotide Excision Resistance Mutations in Cerebrospinal Fluid Is
Associated with Reduced Prevalence of HIV-Related Brain Lesions
C Pierotti, M Nebuloni, A Bestetti, et al
 (11 CROI)
 Abstract
   
  Antiretroviral Drugs Penetrating CSF Do Not Influence Neurocognitive Performance in
HIV-1 -infected Patients Responders to HAART
A Antinori, P Balestra, M L Giancola,  et al
 (11 CROI)
 Abstract

Adjunctive Therapies

          Journal Papers, Abstracts, and Commentaries

  Adjunctive therapies for HIV-1 associated neurologic disease.
Perry SW, Norman JP, Gelbard HA.
Neurotox Res. 2005 Oct;8(1,2):161-166.
 Abstract
Diagnosis/Diagnostics
       

          Journal Papers, Abstracts, and Commentaries

 
Cerebral function testing differs in HIV-infected subjects with and without
chronic HCV co-infection.
 Thiyagarajan A, Garvey LJ, Pflugrad H, et al
Clin Microbiol Infect. 2010 Feb 2
 Abstract

Positron emission tomography imaging in human immunodeficiency virus-1-associated
neurocognitive disorders: an interesting case and a review of the positron emission
tomography literature.
Meyer PT, Gobbelé R, Ludolph A, et al
Clin Nucl Med. 2009 Aug;34(8):496-9.
 Abstract

NeuroAIDS: Characteristics and Diagnosis of the Neurological Complications of AIDS.
Minagar A, Commins D, Alexander JS, et al
Mol Diagn Ther. 2008;12(1):25-43.
 Abstract
 
Clinical validation of the NeuroScreen.
Ellis RJ, Evans SR, Clifford DB, Moo LR, et al
J Neurovirol. 2005 Dec;11(6):503-511.
 Abstract
 
Neuroimaging in human immunodeficiency virus infection.
Tucker KA, Robertson KR, Lin W 
J Neuroimmunol. 2004 Dec;157(1-2):153-62.
 Abstract
 
Correlation between clinical diagnostic test and neuropathological findings in patients
with AIDS
Akova-Ozturk E, Evers S, Colak-Ekici R, et al
Nervenarzt. 2004 Apr 28
 Abstract
 
  Neuroimaging of HIV and AIDS related illnesses: a review.
 Bakshi R.
 Front Biosci. 2004 Jan 1;9:632-646.
 Abstract
Oncology
       

      Journal Papers, Abstracts, and Commentaries  

  Intracerebral Hodgkin's lymphoma in a patient with human immunodeficiency virus.
García-Noblejas A, Nieto S, et al 
Haematologica. 2007 Jun;92(6):e72-3
 Abstract

HIV Systemic Disease Main New/Newsworthy  Home Page

HIV-Associated Nervous System Disorders